Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-151759)

Filing Details

Accession Number:: 0001209191-16-151759
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-11-22 17:31:48
Reporting Period:: 2016-11-17

Filing Date:: 2016-11-22
Accepted Time:: 2016-11-22 17:31:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604464	Atara Biotherapeutics Inc.	ATRA	Biological Products, (No Disgnostic Substances) (2836)	460920988

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612090	Gad Soffer	611 Gateway Boulevard Suite 900 South San Francisco CA 94080	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-11-17	1,480	$18.41	230,812	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Transaction pursuant to Rule 10b5-1 Plan adopted September 26, 2016.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $18.10 to $18.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.